...
首页> 外文期刊>MBio >Low-Level Antimicrobials in the Medicinal Leech Select for Resistant Pathogens That Spread to Patients
【24h】

Low-Level Antimicrobials in the Medicinal Leech Select for Resistant Pathogens That Spread to Patients

机译:药用水ch中的低水平抗菌药物选择可传播给患者的耐药病原体

获取原文
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT Fluoroquinolones (FQs) and ciprofloxacin (Cp) are important antimicrobials that pollute the environment in trace amounts. Although Cp has been recommended as prophylaxis for patients undergoing leech therapy to prevent infections by the leech gut symbiont Aeromonas , a puzzling rise in Cp-resistant (Cp~(r)) Aeromonas infections has been reported. We report on the effects of subtherapeutic FQ concentrations on bacteria in an environmental reservoir, the medicinal leech, and describe the presence of multiple antibiotic resistance mutations and a gain-of-function resistance gene. We link the rise of Cp~(r) Aeromonas isolates to exposure of the leech microbiota to very low levels of Cp (0.01 to 0.04?μg/ml), <1/100 of the clinical resistance breakpoint for Aeromonas . Using competition experiments and comparative genomics of 37 strains, we determined the mechanisms of resistance in clinical and leech-derived Aeromonas isolates, traced their origin, and determined that the presence of merely 0.01?μg/ml Cp provides a strong competitive advantage for Cp~(r)strains. Deep-sequencing the Cp~(r)-conferring region of gyrA enabled tracing of the mutation-harboring Aeromonas population in archived gut samples, and an increase in the frequency of the Cp~(r)-conferring mutation in 2011 coincides with the initial reports of Cp~(r) Aeromonas infections in patients receiving leech therapy. IMPORTANCE The role of subtherapeutic antimicrobial contamination in selecting for resistant strains has received increasing attention and is an important clinical matter. This study describes the relationship of resistant bacteria from the medicinal leech, Hirudo verbana , with patient infections following leech therapy. While our results highlight the need for alternative antibiotic therapies, the rise of Cp~(r)bacteria demonstrates the importance of restricting the exposure of animals to antibiotics approved for veterinary use. The shift to a more resistant community and the dispersion of Cp~(r)-conferring mechanisms via mobile elements occurred in a natural setting due to the presence of very low levels of fluoroquinolones, revealing the challenges of controlling the spread of antibiotic-resistant bacteria and highlighting the importance of a holistic approach in the management of antibiotic use.
机译:摘要氟喹诺酮类(FQs)和环丙沙星(Cp)是重要的抗菌剂,它们会污染痕量环境。尽管已建议使用Cp预防进行水ech治疗的患者,以预防水ech肠道共生菌气单胞菌的感染,但已报道了对Cp耐药(Cp〜(r))气单胞菌感染的令人困惑的上升。我们报告了亚治疗FQ浓度对环境水库中的细菌,药用水ech的影响,并描述了多种抗生素耐药性突变和功能获得性耐药基因的存在。我们将Cp〜(r)气单胞菌分离株的上升与水ech微生物群暴露于极低水平的Cp(0.01至0.04?μg/ ml)(小于气单胞菌临床耐药点的1/100)联系起来。通过竞争实验和37个菌株的比较基因组学,我们确定了临床和水ech来源的气单胞菌分离株的耐药机制,追踪了它们的起源,并确定仅0.01μg/ ml Cp的存在为Cp〜提供了强大的竞争优势。 (r)株。对gyrA赋予Cp〜(r)的区域进行深度测序可以追踪存档的肠道样本中携带突变的气单胞菌种群,2011年赋予Cp〜(r)的突变的频率与初始接受水ech治疗的患者中Cp〜(r)气单胞菌感染的报道。重要信息亚治疗性抗生素污染在选择耐药菌株中的作用已受到越来越多的关注,并且是重要的临床问题。这项研究描述了药用水echHirudo verbana的耐药细菌与水le治疗后患者感染的关系。尽管我们的研究结果突出了对替代抗生素治疗的需求,但Cp〜(r)细菌的出现证明了限制动物接触批准用于兽医的抗生素的重要性。由于存在非常低水平的氟喹诺酮类药物,在自然环境中发生了向更具抗药性的群落的转移以及通过移动元件使Cp〜(r)赋予机制的分散,这是由于氟喹诺酮类药物的水平非常低,这揭示了控制耐药性细菌扩散的挑战并强调在抗生素使用管理中采用整体方法的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号